Female preclinical presenilin-1 mutation carriers unaware of their genetic status have higher levels of depression than their non-mutation carrying kin

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 75, Issue 3, 2004, Pages 500-502

  Ringman, J M ^a   Diaz Olavarrieta, C ^c   Rodriguez, Y ^c   Chavez, M ^c   Paz, F ^c   Murrell, J ^d   Macias, M Angel ^e   Hill, M ^b   Kawas, C ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGY AND NEUROSURGERY   (Mexico)

^d INDIANA UNIVERSITY   (United States)

^e UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; PRESENILIN 1;

ADULT; AGE DISTRIBUTION; ALZHEIMER DISEASE; AMNESIA; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; COVARIANCE; DEPRESSION; EDUCATION; FEMALE; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC RISK; HETEROZYGOTE; HUMAN; MEMORY; MINI MENTAL STATE EXAMINATION; MUTATION; NEUROPSYCHOLOGICAL TEST; PREDICTION; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; REGRESSION ANALYSIS; RISK FACTOR; SCORING SYSTEM;

ADULT; AFFECT; ALZHEIMER DISEASE; CROSS-SECTIONAL STUDIES; DEPRESSION; DISEASE PROGRESSION; FEMALE; GENETIC SCREENING; HUMANS; MEMBRANE PROTEINS; MEMORY DISORDERS; PRESENILIN-1; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; RISK FACTORS;

EID: 1542512000     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2002.005025     Document Type: Article

References (24)

1. Mega MS, Cummings JL, Fiorello T, et al. The spectrum of behavioral changes in Alzheimer's disease. Neurology 1996;46:130-5.
2. Wetherell JL, Gatz M, Johansson B, et al. History of depression and other psychiatric illness as risk factors far Alzheimer disease in a twin sample. Alzheimer Dis Assoc Disord 1999;13:47-52.
3. Berger AK, Fratiglioni L, Forsell Y, et al. The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology 1999;53:1998-2002.
4. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59.
5. Troncoso JC, Cataldo AM, Nixon RA, et al. Neuropathology of preclinical and clinical late-onset Alzheimer's disease. Ann Neurol 1998;43:673-6.
6. Jorm AF, van Duijn CM, Chandra V, et al. Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol 1991;20:S43-7.
7. Agbayewa MO. Earlier psychiatric morbidity in patients with Alzheimer's disease. J Am Geriatr Soc 1986;34:561-4.
8. Shalat SL, Seltzer B, Pidcock C, et al. Risk factors for Alzheimer's disease: a case-control study. Neurology 1987;37:1630-3.
9. Kokmen E, Beard CM, Chandra V, et al. Clinical risk factors for Alzheimer's disease: a population-based case-control study. Neurology 1991;41:1393-7.
10. Reding M, Haycox J, Blass J. Depression in patients referred to a dementia clinic. A three-year prospective study. Arch Neurol 1985;42:894-6.
11. Devanand DP, Sano M, Tang MX, et al. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry 1996;53:175-82.
12. Kennedy AM, Newman S, McCaddon A, et al. Familial Alzheimer's disease. A pedigree with a missense mutation in the amyloid precursor protein gene (amyloid precursor protein 717 valine→glycine). Brain 1993;116:309-24.
13. Lopera F, Ardilla A, Martinez A, et al. Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation. JAMA 1997;277:793-9.
14. Lowenberg K, Waggoner RW. Familial organic psychosis (Alzheimer's type). Arch Neurol Psychiatry 1934;31:737-54.
15. Heston LL, Lowther DLVV, Levanthal CW. Alzheimer's disease: a family study. Arch Neurol 1966;15:225-33.
16. Feldman RG, Chandler KA, Levy LL, et al. Familial Alzheimer's disease. Neurology 1988;13:14-19.
17. Ringman JM, Jain V, Murrell J, et al. A novel Ala431 Glu mutation in Presenilin-1 associated with familial early-onset Alzheimer's disease [abstract]. Hum Genet 2001;109:242.
18. Cochran EJ, Murrell JR, Fox J, et al. A novel mutation in the Presenilin-1 gene (A431E) associated with early-onset Alzheimer's disease [abstract]. J Neuropathol Exp Neurol 2001;60:544.
19. Murrell JR, Faber K, Alonso ME, et al. The A431E Presenilin 1 gene mutation associated with familial Alzheimer's disease in individuals of Mexican descent: evidence for a founder effect [abstract]. J Neuropathol Exp Neurol 2003;62:543.
20. Diaz-Olavarrieta C, Ostrosky-Solis F, Garcia de la Cadena C, et al. Neuropsychological changes in subjects at risk of inheriting Alzheimer's disease. Neuroreport 1997;8:2449-53.
21. Salokangas RKR, Vaahtera K, Pacriev S, et al. Gender differences in depressive symptoms. An artefact caused by measurement instruments? J Affect Disord 2002;68:215-20.
22. Jurado S, Villegas E. La estandarizacion del Inventario de Depresion de Beck para los residentes de la ciudad de Mexico. Salud Mental 1998;21:26-31.
23. Wagle AC, Ho LW, Wogle SA, et al. Psychometric behaviour of BDI in Alzheimer's disease patients with depression. Int J Geriatr Psychiatry 2000;15:63-9.
24. Starkstein SE, Chemerinski E, Sabe L, et al. Prospective longitudinal study of depression and anosognosia in Alzheimer's disease. Br J Psychiatry 1997;171:47-52.